What is Paliperidone Teva Pharma used for?

Paliperidone Teva Pharma

Active Ingredient:: Paliperidone Palmitate
Origin:: EU

Paliperidone Teva Pharma (Paliperidone Palmitate)

Paliperidone palmitate, the active ingredient in Paliperidone Teva Pharma, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the treatment of schizophrenia in adult patients. GNH India supplies Paliperidone Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH India supplies Paliperidone Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Teva Pharma B.V.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Paliperidone palmitate is a long‑acting injectable antipsychotic that works within the dopamine‑serotonin pathway to manage psychotic disorders.

Schizophrenia: helps reduce the frequency of relapse and maintain symptom control in adults.
Schizoaffective disorder: contributes to stabilization of mood and psychotic symptoms when used as part of a comprehensive treatment plan.
Maintenance therapy after acute episode: provides sustained medication levels to support ongoing management after an initial stabilization phase.

How It Works

Paliperidone palmitate is a depot formulation of paliperidone that slowly releases the active moiety after intramuscular injection. The drug acts as an antagonist at dopamine D2 and serotonin 5‑HT2A receptors, reducing dopaminergic neurotransmission and modulating serotonergic activity, which together help alleviate psychotic symptoms.

Side Effects

Paliperidone palmitate may cause a range of adverse reactions, most of which are dose‑dependent and often diminish over time.

Common Side Effects

Injection site pain or erythema
Headache
Fatigue
Restlessness (akathisia)
Nausea
Weight gain

Serious or Rare Side Effects

Neuroleptic malignant syndrome
Tardive dyskinesia
Severe orthostatic hypotension
Hyperglycaemia or new‑onset diabetes mellitus
Seizures
Elevated prolactin levels causing galactorrhoea or menstrual disturbances

Precautions & Warnings

When prescribing Paliperidone Teva Pharma, clinicians should consider several safety aspects.

Cardiovascular assessment: evaluate for history of arrhythmias or QT prolongation.
Metabolic monitoring: check blood glucose and lipid profiles regularly.
Movement disorders: observe for signs of tardive dyskinesia or akathisia.
Pregnancy and lactation: weigh potential benefits against risks; use only if clearly needed.
Elderly patients: start at lower doses and monitor for orthostatic hypotension.
Store at room temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Paliperidone palmitate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase paliperidone exposure.
CNS depressants (e.g., benzodiazepines, opioids): additive sedation and respiratory depression risk.

Moderate Interactions (Monitor Closely):\n- Antihypertensives: may enhance orthostatic hypotension.

Antidiabetic agents: potential for altered glucose control.
Other antipsychotics: increased risk of QT prolongation and extrapyramidal symptoms.

Frequently Asked Questions

Paliperidone Teva Pharma is a long‑acting injectable antipsychotic indicated for the treatment of schizophrenia in adults, and it may also be used as part of maintenance therapy after an acute psychotic episode.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 11 Oct 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.